Interactions between Terpinen-4-ol and Nystatin on biofilm of Candida albicans and Candida tropicalis.

The aim of this study was to evaluate the antifungal activity of Terpinen-4-ol associated with nystatin, on single and mixed species biofilms formed by Candida albicans and Candida tropicalis, as well as the effect of terpinen-4-ol on adhesion in oral cells and the enzymatic activity. The minimum inhibitory concentrations and minimum fungicide concentrations of terpinen-4-ol and nystatin on Candida albicans and Candida tropicalis were determined using the microdilution broth method, along with their synergistic activity ("checkerboard" method). Single and mixed species biofilms were prepared using the static microtiter plate model and quantified by colony forming units (CFU/mL). The effect of Terpinen-4-ol in adhesion of Candida albicans and Candida tropicalis in coculture with oral keratinocytes (NOK Si) was evaluated, as well as the enzymatic activity by measuring the size of the precipitation zone, after the growth agar to phospholipase, protease and hemolysin. Terpinen-4-ol (4.53 mg mL-1) and nystatin (0.008 mg mL-1) were able to inhibit biofilms growth, and a synergistic antifungal effect was showed with the drug association, reducing the inhibitory concentration of nystatin up to 8 times in single biofilm of Candida albicans, and 2 times in mixed species biofilm. A small decrease in the adhesion of Candida tropicalis in NOK Si cells was showed after treatment with terpinen-4-ol, and nystatin had a greater effect for both species. For enzymatic activity, the drugs showed no action. The effect potentiated by the combination of terpinen-4-ol and nystatin and the reduction of adhesion provide evidence of its potential as an anti-fungal agent.

[1]  J. C. Junqueira,et al.  Study of Microbial Interaction Formed by "Candida krusei" and "Candida glabrata": "In Vitro" and "In Vivo" Studies. , 2017, Brazilian dental journal.

[2]  A. Delpisheh,et al.  Anti-fungal resistance in candida isolated from oral and diaper rash candidiasis in neonates , 2014, Bioinformation.

[3]  I. Ahmad,et al.  Sub-MICs of Carum copticum and Thymus vulgaris influence virulence factors and biofilm formation in Candida spp , 2014, BMC Complementary and Alternative Medicine.

[4]  L. Samaranayake,et al.  Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals , 2014, Mycopathologia.

[5]  C. Rossa Junior,et al.  Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages , 2014, Inflammation Research.

[6]  B. Sadowska,et al.  Enzymatic profile, adhesive and invasive properties of Candida albicans under the influence of selected plant essential oils. , 2014, Acta Biochimica Polonica.

[7]  N. Manzoor,et al.  Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  T. Riley,et al.  Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil. , 2012, Medical mycology.

[9]  J. F. Höfling,et al.  Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis. , 2012, Medical mycology.

[10]  J. Bagg,et al.  Antifungal, Cytotoxic, and Immunomodulatory Properties of Tea Tree Oil and Its Derivative Components: Potential Role in Management of Oral Candidosis in Cancer Patients , 2012, Front. Microbio..

[11]  C. Biçmen,et al.  Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus. , 2012, The new microbiologica.

[12]  R. Gonçalves,et al.  Periodontal conditions and prevalence of putative periodontopathogens and Candida spp. in insulin-dependent type 2 diabetic and non-diabetic patients with chronic periodontitis--a pilot study. , 2011, Archives of oral biology.

[13]  X. S. Passos,et al.  Effects of Antifungal Agents in Sap Activity of Candida albicans Isolates , 2010, Mycopathologia.

[14]  A. Cione,et al.  Development and validation of an HPLC method for stability evaluation of nystatin , 2010 .

[15]  G. Cristalli,et al.  Composition and biological activity of essential oil of Achillea ligustica All. (Asteraceae) naturalized in central Italy: ideal candidate for anti-cariogenic formulations. , 2009, Fitoterapia.

[16]  Mrudula Patel,et al.  The effect of Dodonaea viscosa var. angustifolia on Candida albicans proteinase and phospholipase production and adherence to oral epithelial cells. , 2009, Journal of ethnopharmacology.

[17]  Shujuan Sun,et al.  In Vitro Interactions between Tacrolimus and Azoles against Candida albicans Determined by Different Methods , 2007, Antimicrobial Agents and Chemotherapy.

[18]  W. Leung,et al.  Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. , 2007, Journal of medical microbiology.

[19]  A. Cassone,et al.  In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species , 2006, BMC infectious diseases.

[20]  T. Riley,et al.  Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties , 2006, Clinical Microbiology Reviews.

[21]  J. Trouillas,et al.  Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats. , 2004, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[22]  T. Riley,et al.  Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. , 2004, The Journal of antimicrobial chemotherapy.

[23]  J. Perfect,et al.  Combination Antifungal Therapy , 2004, Antimicrobial Agents and Chemotherapy.

[24]  H. Yamaguchi,et al.  Effect of Sealing and Tween 80 on the Antifungal Susceptibility Testing of Essential Oils , 2001, Microbiology and immunology.

[25]  A. Fusco-Almeida,et al.  Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. , 2013, Journal of medical microbiology.

[26]  R. Cordeiro,et al.  Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. , 2013, Medical mycology.

[27]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .